KalVista Pharma Terminates KVD824 Phase 2 KOMPLETE Trial For Prophylactic Treatment Of HAE

RTTNews | 1051 dagar sedan
Stocktwits
KalVista Pharma Terminates KVD824 Phase 2 KOMPLETE Trial For Prophylactic Treatment Of HAE

(RTTNews) - KalVista Pharmaceuticals, Inc. (KALV) announced Monday that it has terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema (HAE).

This decision was based on the observation of liver enzyme (ALT/AST) elevations in multiple patients in all treatment groups of the trial. No patients had concomitant elevation of bilirubin levels and all were asymptomatic.

The KOMPLETE trial is a phase 2 clinical trial evaluating KVD824, an investigational oral plasma kallikrein inhibitor designed for the prevention of attacks in adults living with HAE.

Patients in the trial were randomized to one of three treatment groups, each placebo controlled: 300 mg, 600 mg, 900 mg KVD824 (or placebo), all dosed twice daily.

KalVista continues to recruit the phase 3 KONFIDENT trial assessing sebetralstat (formerly KVD900) as a potential oral, on-demand therapy for HAE attacks, with data anticipated in the second half of 2023.

For More Such Health News, visit rttnews.com

Taggar: KALV
Stocktwits
read more
KalVista Pharma Appoints Brian Piekos As New CFO

KalVista Pharma Appoints Brian Piekos As New CFO

KalVista Pharmaceuticals, Inc. (KALV) announced Tuesday that Brian Piekos has joined the Company as Chief Financial Officer (CFO). Piekos is an experienced public company CFO who brings a demonstrated track record of successfully leading companies across the biotechnology sector.
RTTNews | 345 dagar sedan
European Shares Seen Flat To Higher At Open

European Shares Seen Flat To Higher At Open

European stocks are seen opening flat to slightly higher on Thursday as investors await the latest PMI data from the region and look forward to key speeches from Fed officials when they convene in Jackson Hole, Wyoming, for the Fed's annual economic symposium.
RTTNews | 1h 31minuter sedan
European Economic News Preview: Eurozone Flash PMI Data Due

European Economic News Preview: Eurozone Flash PMI Data Due

Flash Purchasing Managers' survey results from the euro area and the UK are the top economic news due on Thursday. At 2.00 am ET, the Office for National Statistics publishes UK public sector finance data. At 3.15 am ET, S&P Global publishes France flash PMI survey results.
RTTNews | 1h 36minuter sedan
Sensex, Nifty Extend Gains In Cautious Trade

Sensex, Nifty Extend Gains In Cautious Trade

Indian shares traded higher for a sixth consecutive session on Thursday, though overall gains remained limited due to mixed global cues ahead of the Federal Reserve's annual symposium at Jackson Hole, Wyoming, from August 21 to August 23, where Fed Chairman Jerome Powell is due to speak.
RTTNews | 2h 27minuter sedan
Australian Market Extends Early Gains In Mid-market

Australian Market Extends Early Gains In Mid-market

The Australian market is extending early gains in mid-market moves on Thursday, adding to the gains in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving up to near the 9,000 mark to fresh all-time highs, with gains across most sectors led by mining, financial and energy stocks.
RTTNews | 3h 44minuter sedan
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, following the mixed cues from Wall Street overnight, after reports indicated the Trump administration is looking into the federal government taking equity stakes in Intel and other chipmakers in return for the federal subsidies. Traders also remain optimistic about the US Fed cutting interest rates is September.
RTTNews | 4h 7minuter sedan
Renewed Selling Pressure Tipped For Thai Stock Market

Renewed Selling Pressure Tipped For Thai Stock Market

The Thai stock market on Wednesday wrote a finish to the four-day losing streak in which it had slumped more than 40 points or 3.5 percent. The Stock Exchange of Thailand now sits just beneath the 1,250-point plateau although it may hand back those gains on Thursday.
RTTNews | 5h 10minuter sedan
Verktyg
Ekonomisk kalender
Marknadstider
Räntesatser
Helgdagskalender
Forex Marknad
Forex Volatilitet
Forex Korrelation
Forex Nyheter
Forexanalys
COT Data
Likviditet
Forex Kalkylatorer
Forex värmekarta
Värmekarta över indikatorer
Gemenskapen
Gemenskapen
Systems
De mest populära systemen
Strategier
Tävlingar
Forex Diagram
Forex Sentiment
Indikator för utsikter
Recensioner
Mäklare
Prop trading-företag
VPS-tjänster
Signalleverantörer
EA-programmeringstjänster
Affiliateprogram
PAMM mäklartjänster
Tjänster för rabattprogram
Trading Plattformar
Expertrådgivare
krypto Börser
Tradingkurser
Mäklare
Forex Sprider sig
Forex Citat från mäklare
Forex mäklare Swaps
Forex Volym för mäklare
Forex Kampanjer för mäklare
Pressmeddelande
Plattform
Widgetar
Funktioner
API
RSS
Stock Portfolio
Affiliate Software
Avancerade diagram
Stöd
Vanliga frågor
Hjälp
Kontakta oss
Rapportera en bugg!
Om
Blogg
© 2025 Myfxbook Ltd. Alla rättigheter reserverade
HIGH RISK WARNING: Valutahandel innebär en hög risknivå som kanske inte är lämplig för alla investerare. Hävstångseffekten skapar ytterligare risker och förlustexponering. Innan du bestämmer dig för att handla med utländsk valuta bör du noga överväga dina investeringsmål, din erfarenhetsnivå och din risktolerans. Du kan förlora en del av eller hela din ursprungliga investering. Investera inte pengar som du inte har råd att förlora. Utbilda dig om de risker som är förknippade med valutahandel och sök råd från en oberoende finansiell eller skatterådgivare om du har några frågor. Alla uppgifter och all information tillhandahålls endast i informationssyfte och är inte avsedda för handelsändamål eller rådgivning. Tidigare resultat är inte en indikation på framtida resultat.